OPDIVO 10 mg/mL concentrate for solution for infusion

Company
Bristol-Myers Squibb Pharma EEIG
Active Ingredient
Dosage Form
Concentrate for solution for infusion
Legal Category
A - prescription, may not be renewed
Date of revision
10/2026

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/15/1014/001 10 milligram(s)/millilitre Concentrate for solution for infusion
EU/1/15/1014/002 10 milligram(s)/millilitre Concentrate for solution for infusion
EU/1/15/1014/003 10 milligram(s)/millilitre Concentrate for solution for infusion
EU/1/15/1014/004 10 milligram(s)/millilitre Concentrate for solution for infusion
Licence number
EU/1/15/1014/001
Strength
10 milligram(s)/millilitre
ATC Code
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/15/1014/002
Strength
10 milligram(s)/millilitre
ATC Code
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/15/1014/003
Strength
10 milligram(s)/millilitre
ATC Code
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/15/1014/004
Strength
10 milligram(s)/millilitre
ATC Code
Dosage Form
Concentrate for solution for infusion

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Telephone
+3531800749749
Email
medical.information@bms.com